Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti (Q40548538)
Jump to navigation
Jump to search
scientific article published on 3 October 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti |
scientific article published on 3 October 2003 |
Statements
1 reference
Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis anti (English)
1 reference
Thomas P Monath
1 reference
Farshad Guirakhoo
1 reference
Richard Nichols
1 reference
Sutee Yoksan
1 reference
Robert Schrader
1 reference
Chris Murphy
1 reference
Paul Blum
1 reference
Stephen Woodward
1 reference
Karen McCarthy
1 reference
Danell Mathis
1 reference
Casey Johnson
1 reference
Philip Bedford
1 reference
3 October 2003
1 reference
1 reference
Identifiers
1 reference